115 related articles for article (PubMed ID: 11367603)
1. Predicting readmission to substance abuse treatment using state information systems. The impact of client and treatment characteristics.
Luchansky B; He L; Krupski A; Stark KD
J Subst Abuse; 2000; 12(3):255-70. PubMed ID: 11367603
[TBL] [Abstract][Full Text] [Related]
2. Treatment readmissions and criminal recidivism in youth following participation in chemical dependency treatment.
Luchansky B; He L; Longhi D; Krupski A; Stark KD
J Addict Dis; 2006; 25(1):87-94. PubMed ID: 16597576
[TBL] [Abstract][Full Text] [Related]
3. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
French MT; Salomé HJ; Carney M
Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
[TBL] [Abstract][Full Text] [Related]
4. Completion rates of clients discharged from drug and alcohol treatment programs in Washington State.
Wickizer T; Maynard C; Atherly A; Frederick M; Koepsell T; Krupski A; Stark K
Am J Public Health; 1994 Feb; 84(2):215-21. PubMed ID: 8296943
[TBL] [Abstract][Full Text] [Related]
5. Impact of substance abuse treatment on arrests among opiate users in Washington State.
Campbell KM; Deck D; Krupski A
Am J Addict; 2007; 16(6):510-20. PubMed ID: 18058419
[TBL] [Abstract][Full Text] [Related]
6. Chemical dependency treatment and employment outcomes: results from the 'ADATSA' program in Washington State.
Luchansky B; Brown M; Longhi D; Stark K; Krupski A
Drug Alcohol Depend; 2000 Aug; 60(2):151-9. PubMed ID: 10940542
[TBL] [Abstract][Full Text] [Related]
7. Managed care and the quality of substance abuse treatment.
Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
[TBL] [Abstract][Full Text] [Related]
8. Impact of Agency Receipt of Incentives and Reminders on Engagement and Continuity of Care for Clients With Co-Occurring Disorders.
Lee MT; Acevedo A; Garnick DW; Horgan CM; Panas L; Ritter GA; Campbell KM
Psychiatr Serv; 2018 Jul; 69(7):804-811. PubMed ID: 29695226
[TBL] [Abstract][Full Text] [Related]
9. The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.
Krawczyk N; Feder KA; Saloner B; Crum RM; Kealhofer M; Mojtabai R
Drug Alcohol Depend; 2017 Jun; 175():157-163. PubMed ID: 28432939
[TBL] [Abstract][Full Text] [Related]
10. Improving publicly funded substance abuse treatment: the value of case management.
Shwartz M; Baker G; Mulvey KP; Plough A
Am J Public Health; 1997 Oct; 87(10):1659-64. PubMed ID: 9357349
[TBL] [Abstract][Full Text] [Related]
11. Organizational and client determinants of cost in outpatient substance abuse treatment.
Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
[TBL] [Abstract][Full Text] [Related]
12. Stay in residential facilities and mental health care as predictors of readmission for patients with substance use disorders.
Moos RH; Moos BS
Psychiatr Serv; 1995 Jan; 46(1):66-72. PubMed ID: 7895125
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of full vs. partial continuum of care in the treatment of publicly funded substance abusers in Washington State.
McKay JR; Donovan DM; McLellan T; Krupski A; Hansten M; Stark KD; Geary K; Cecere J
Am J Drug Alcohol Abuse; 2002; 28(2):307-38. PubMed ID: 12014818
[TBL] [Abstract][Full Text] [Related]
14. Are Washington Circle performance measures associated with decreased criminal activity following treatment?
Garnick DW; Horgan CM; Lee MT; Panas L; Ritter GA; Davis S; Leeper T; Moore R; Reynolds M
J Subst Abuse Treat; 2007 Dec; 33(4):341-52. PubMed ID: 17524596
[TBL] [Abstract][Full Text] [Related]
15. The impact of managed care on publicly funded outpatient adolescent substance abuse treatment: service use and six-month outcomes in Oregon and Washington.
Carlson MJ; Gabriel RM; Deck DD; Laws KE; D'Ambrosio R
Med Care Res Rev; 2005 Jun; 62(3):320-38. PubMed ID: 15894707
[TBL] [Abstract][Full Text] [Related]
16. Does case mix matter for substance abuse treatment? A comparison of observed and case mix-adjusted readmission rates for inpatient substance abuse treatment in the Department of Veterans Affairs.
Phibbs CS; Swindle RW; Recine B
Health Serv Res; 1997 Feb; 31(6):755-71. PubMed ID: 9018215
[TBL] [Abstract][Full Text] [Related]
17. Program characteristics and readmission among older substance abuse patients: comparisons with middle-aged and younger patients.
Moos RH; Mertens JR; Brennan PL
J Ment Health Adm; 1995; 22(4):332-45. PubMed ID: 10172450
[TBL] [Abstract][Full Text] [Related]
18. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?
Ettner SL; Huang D; Evans E; Ash DR; Hardy M; Jourabchi M; Hser YI
Health Serv Res; 2006 Feb; 41(1):192-213. PubMed ID: 16430607
[TBL] [Abstract][Full Text] [Related]
19. Drug abuse treatment outcome study of adolescents: a comparison of client characteristics and pretreatment behaviors in three treatment modalities.
Rounds-Bryant JL; Kristiansen PL; Hubbard RL
Am J Drug Alcohol Abuse; 1999 Nov; 25(4):573-91. PubMed ID: 10548436
[TBL] [Abstract][Full Text] [Related]
20. Engagement in outpatient substance abuse treatment and employment outcomes.
Dunigan R; Acevedo A; Campbell K; Garnick DW; Horgan CM; Huber A; Lee MT; Panas L; Ritter GA
J Behav Health Serv Res; 2014 Jan; 41(1):20-36. PubMed ID: 23686216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
